(Reuters) – Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail (casirivimab and imdevimab) reduced the…
Read MoreFrench drug firm Valneva reports positive results from its Covid trial
French drug firm Valneva – whose UK contract for 100million Covid vaccines was cancelled last month – says its jab…
Read MoreResearchers identify new drug target for blood cancer, potentially solid tumors
Mount Sinai and UC San Diego researchers have shown for the first time how mutations affecting a cellular process called…
Read MoreCommon diabetes drug shows promise against rare childhood brain tumor in laboratory studies
Metformin, a drug commonly prescribed against diabetes, holds promise against a rare type of childhood brain tumor in laboratory studies,…
Read MoreLinking US prescription drug prices to those paid in other nations could cut costs in half
Linking the cost of prescription drugs in the United States to the prices paid in other high-income nations could have…
Read MoreU.S. drug overdose deaths jumped nearly 30% during pandemic
(HealthDay)—As America went into lockdown and treatment centers closed their doors, drug overdose deaths in the United States jumped by…
Read MoreAnti-coagulant drug could treat COVID-19s emerging variants
Molecules from the same family as the anti-coagulant drug heparin may interfere with the ability of the COVID-19 virus’s spikes…
Read MoreDrug demonstrates poor efficacy in advanced bladder cancer
An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial published…
Read MoreExperimental drug shows potential against Alzheimer’s disease
Researchers at Albert Einstein College of Medicine have designed an experimental drug that reversed key symptoms of Alzheimer’s disease in…
Read MoreDrug coupons and vouchers cover only a sliver of prescription drugs
Use of vouchers and coupons offered by pharmaceutical companies to defray patients’ out-of-pocket drug costs is concentrated among a small…
Read More